Dynatronics CORP. Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 9/27/2024)
| Balance Sheet | Total Assets | 25,940,600.00 | ROE | – |
| Balance Sheet | Total Equity | 14,160,400.00 | ROA | – |
| Cashflow | Capital Expenditures | -243,287.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -1,853,687.00 | – | – |
| Cashflow | Operating Cash Flow | -1,610,400.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -1.00 | Div. Yield | – |
| Income | Net Income | -2,697,720.00 | P/E | – |
| Income | Shares Outstanding | 3,421,610.00 | P/B | – |
| Income | Total Revenue | 32,534,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Dynatronics Corporation (Dynatronics) is engaged in the distribution and marketing of physical medicine and aesthetic products many of, which the Company designs and manufactures. The products are of two categories: physical medicine products and aesthetic products. Dynatronics manufactures and distributes a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Dynatronics´s products are used primarily by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Dynatronics also manufactures and distributes a line of aesthetic equipment, including aesthetic massage and microdermabrasion devices, as well as skin care products. These products are used by aestheticians, plastic surgeons, dermatologists and other aesthetic services providers.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.dynatronics.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more